Cureus, 14(1), e21476
Among those who voted yes was Kris Wusterhausen, a recent addition to the committee who is a doctor and the founder of a Texas wellness clinic that recommends peptides, including BPC-157
Explored deeply in complex inflammatory response and recovery-focused studies
By combining these components, GLOW provides a consistent platform to investigate collagen-related signaling, soft-tissue remodeling, and inflammation-balance pathways in preclinical and in-vitro models
Possible modest effects on dihydrotestosterone (DHT) activity , suggested by some in vitro studies
\n\n\n\n This guide covers what the current scientific literature reveals about BPC-157: how it appears to work, what conditions it has been studied in, what the preclinical safety data shows, and where the critical gaps in human evidence remain